Retrieved from Rohatgi, K
A sublingual tirzepatide protocol designed to support weight loss, energy, and metabolic health by working with your bodys natural hormonal signaling pathways
Ligand-specific factors influencing glp-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells
Retatrutide is an investigational compound and is not an approved medicine in any jurisdiction as of April 2026
Previously, a nationwide shortage in GLP-1 medications made it possible to access compounded versions of the drugs, but the FDA has officially announced the end of that shortage and said it will take decisive steps to restrict companies making compounded GLP-1s from accessing those ingredients
The key strategies for minimizing regain during a short break include maintaining a high protein intake of 1.6-2.2 grams per kilogram of body weight daily, continuing or increasing resistance training to preserve muscle mass, planning meals in advance so hunger does not drive impulsive food choices, monitoring weight weekly but not daily to avoid overreacting to normal fluctuations, and staying hydrated since the body may retain more water without GLP-1 mediated effects on fluid balance
